Kevin Han is a Vice President of Morgan Stanley Expansion Capital. Most recently, Mr. Han led financial operations and strategic planning as Chief Financial Officer at Biological Dynamics. Prior to that, he led investor relations, corporate communications, and sustainability strategies at Bio-Rad Laboratories (NYSE: BIO). He, also, held senior leadership positions as a Portfolio Manager at various asset management firms, Lombard Odier, BlueCrest, and Visium, where he led diligence and investments on numerous IPOs and financings. Mr. Han started his career at Morgan Stanley, and later Goldman Sachs, where his team was named #1 Best Up & Comer by Institutional Investor, covering the medical technology and diagnostics sectors. Mr. Han holds a BS in Business Administration from UNC Kenan-Flagler Business School, was pre-med at the University of North Carolina at Chapel Hill, and has completed Executive Education programs at London Business School and Harvard Business School.